Questions over human papillomavirus vaccine in the US and Australia

BMJ 2007; 334 doi: http://dx.doi.org/10.1136/bmj.39237.424537.4E (Published 7 June 2007)
Cite this as: BMJ 2007;334:1182.1

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Janice Hopkins Tanne
  1. New York

    Questions have emerged in the United States and Australia about the effectiveness and possibly dangerous side effects of Gardasil, Merck's newly licensed vaccine for human papillomavirus.

    In the US, three deaths closely time related to immunisation with the vaccine were among 1637 adverse reactions reported by Judicial Watch, a public interest watchdog. Judicial Watch obtained the reports from the Food and Drug Administration using the Freedom of Information Act. The reports were filed through the FDA's vaccine adverse event reporting system.

    In Australia, 25 girls at a Catholic high school in Melbourne who …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL